Bank of America’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-3,508
Closed -$182K – 6684
2025
Q4
$182K Hold
3,508
– – ﹤0.01% 5385
2025
Q3
$149K Hold
3,508
– – ﹤0.01% 6414
2025
Q2
$143K Hold
3,508
– – ﹤0.01% 6340
2025
Q1
$170K Hold
3,508
– – ﹤0.01% 6261
2024
Q4
$154K Hold
3,508
– – ﹤0.01% 6226
2024
Q3
$196K Buy
+3,508
New +$191K ﹤0.01% 6003
2019
Q2
– Sell
-400
Closed -$10K – 7376
2019
Q1
$10K Buy
+400
New +$10.1K ﹤0.01% 6659
2016
Q3
– Sell
-3,200
Closed -$51K – 7320
2016
Q2
$51K Buy
+3,200
New +$49.4K ﹤0.01% 5829
2013
Q4
– Sell
-4,000
Closed -$34K – 8095
2013
Q3
$34K Sell
4,000
-6,320
-61% -$53.3K ﹤0.01% 6642
2013
Q2
$78K Buy
+10,320
New +$78.4K ﹤0.01% 6304

Other funds holding RXL

Bank of America's RXL Position: Q1 2026 in Review

Bank of America sold out of ProShares Ultra Health Care (RXL) in Q1 2026, closing a stake of 3,508 shares — an estimated $182K sold.

Bank of America first reported a position in RXL in Q2 2013 and held it in 10 quarters. The position peaked at $196K in Q3 2024. 17 funds tracked by Wall St. Rank hold RXL as of Q1 2026.

  • Bank of America reported no remaining ProShares Ultra Health Care position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 3,508 ProShares Ultra Health Care shares in Q1 2026, an estimated $182K.
  • Bank of America first reported a position in ProShares Ultra Health Care in Q2 2013 and held it in 10 quarters.
  • Bank of America's ProShares Ultra Health Care position peaked at $196K in Q3 2024.
  • 17 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.